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Edited by Robert BaroukiAbstract Insulin resistant states are associated with an increase
in the beta cell mass and also high levels of circulating insulin.
Ultimately the beta cells undergo a failure that leads to diabetes.
At this stage, a question arises if those persistent high levels of
circulating insulin may contribute to beta cell damage. To ad-
dress this important issue, we submitted beta cells to a prolonged
eﬀect of increasing concentrations of insulin. We observed that a
prolonged eﬀect of high levels of insulin on the presence of serum
(15–24 h) in glucose-deprived beta cells induced apoptosis. This
apoptotic eﬀect was both dose- and cycloheximide-dependent.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Type 2 diabetes results from a combination of insulin resis-
tance and impaired insulin secretion. While there is some de-
bate about the primary defect in type 2 diabetes, insulin
resistance is the most relevant pathophysiological feature in
the prediabetic state [1]. Insulin resistant states are associated
with an increase in the beta cell mass and also high levels of
circulating insulin. In fact, owing to compensatory mecha-
nisms, hyperinsulinemia can persist for years until glucose
intolerance becomes apparent. Ultimately, the beta cells under-
go a failure in the insulin secretion that leads to uncontrolled
diabetes [1]. The molecular mechanisms underlying beta cell
failure are not yet fully understood, it has been proposed that
beta cells die by diﬀerent pathways that include both glucotox-
ic and lipotoxic eﬀects [2–4]. Insulin is a factor that increases
cell proliferation and promotes cell survival in beta cells [5–
9]. In brown adipocytes, a long-term treatment with insulin in-
duces apoptosis [10]. Furthermore, it has been observed that
insulin can induce apoptosis in chick embryo retina in the ab-
sence of L-glutamine during the development [11]. In addition,
insulin and IGF-1 can induce an apoptosis-like phenomenon,
named paraptosis, through IGF-1 receptor in human embry-
onic kidney 293T cells [12]. Overall, these data suggest that
insulin can inhibit or stimulate cell apoptosis depending on*Corresponding author. Present address: Departamento de Bioquı´-
mica y Biologı´a Molecular, Facultad de Farmacia, Universidad
Complutense, Madrid 28040, Spain.
E-mail address: benito@farm.ucm.es (M. Benito).
0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2008.10.020the microenvironment. To address this important issue, we
have submitted neonatal beta cells to a prolonged eﬀect of
increasing concentrations of insulin. Besides its survival eﬀect,
we have found that long-term treatment (15–24 h) with insulin
induced apoptosis in glucose-deprived cells. Furthermore, this
deleterious eﬀect of insulin was dose-dependent, as assessed by
cleaved caspase-3 expression, caspase-3 activity, cell cycle and
cell survival analysis. This proapoptotic eﬀect of insulin was
also dependent on protein synthesis as the addition of cyclo-
heximide, an inhibitor of translational elongation in eukary-
otic organisms, blocked both the apoptotic eﬀect of glucose
deprivation and insulin treatment on glucose-deprived beta
cells.2. Materials and methods
2.1. Reagents
Insulin, cycloheximide, violet crystal, propidium iodide, fetal calf
serum, and beta-actin antibody and glucose were from Sigma Chemi-
cal Co. (St. Louis, MO). Phospho-p70 (Thr 389), phospho-Akt (Ser
473), BclxL, and cleaved caspase-3 Asp 175 antibodies were from Cell
Signaling (Beverly, MA). BclxS and bax antibodies were from Santa
Cruz Biotechnology (Santa Cruz, CA).
2.2. Cell culture and viability
Pancreatic beta cells from IR loxP mice were generated as described
in [6]. Two diﬀerent beta cell pool lines were used, IR +/+ and IR /,
both of them immortalized by transfection with attenuated SV40 large
T antigen.
Exponentially growing beta cells were cultured in DMEM medium
containing 10% fetal bovine serum. Beta cells were transferred to a glu-
cose-free medium immediately before performing the diﬀerent treat-
ments. In some experiments, cells were exposed to increasing
concentrations of glucose with or without the addition of insulin for
24 h. Then, cells were observed under a microscope. The addition of
cycloheximide was 30 min prior to insulin or glucose treatment.
2.3. Caspase-3 activity
Cells were scrapped oﬀ, collected by centrifugation at 2500 · g for
5 min, and lysed at 4 C in 5 mM Tris–HCl, pH 8.0, 20 mM EDTA,
and 0.5% Triton X-100. Lysates were clariﬁed by centrifugation at
13000 · g for 10 min. Reaction mixture contained 25 ll of cellular ly-
sates, 325 ll of assay buﬀer (20 mMHEPES, pH 7.5, 10% glycerol, and
2 mM dithiothreitol) and 20 lM caspase-3 substrate (Ac-DEVD-
AMC). After 2-h incubation in the dark, enzymatic activity was mea-
sured in a luminescence spectrophotometer (LS-50; PerkinElmer Life
and Analytical Sciences, Boston, MA) (k excitation, 380 nm; k emis-
sion, 440 nm).2.4. Protein determination
Protein determination was performed by the Bradford dye method,
using the Bio-Rad reagent and BSA as the standard.blished by Elsevier B.V. All rights reserved.
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At the end of the culture time, cells were scrapped oﬀ, collected by
centrifugation at 2500 · g for 5 min at 4 C, and resuspended in hypo-
tonic isolation buﬀer (1 mM EDTA, 10 mM HEPES, and 50 mM su-
crose, pH 7.6). Then, cells were incubated at 37 C for 5 min and
homogenized. Samples were centrifuged at 10000 · g for 10 min, and
the supernatants containing the cytosolic protein fractions were col-
lected.
2.6. Western blotting
Western blot analysis was performed as described in [6].
2.7. Violet crystal assay
Cells were grown in 12-well plates at a density of 30000 cells/cm2
in DMEM supplemented with FBS 10%. On the next day, cells were
depleted of glucose and insulin was added at diﬀerent doses from
100 pM to 100 nM for 24 h for violet crystal assay. In other experi-
ments, cycloheximide was used for 30 min before the addition of ago-
nists, and was maintained until the end of the experiment. Cells were
washed with PBS and stained with violet crystal (0.2% in 2% ethanol)
for 10 min. Then, plates were rinsed with water, dried, and 1% sodium
dodecyl sulfate was added. Absorbance of each plate was read at
560 nm.Fig. 1. Insulin induces a biphasic eﬀect on mTOR/p70 pathway and cleav
supplemented with FBS 10%. Beta cells were transferred to a glucose-free m
insulin 10 nM for 2–24 h. Total protein extracts were analyzed by immunoblo
389), phospho-Akt (Ser 473), cleaved caspase-3 and beta-actin. (B) Densit
analyzed in (A) is also shown. Results are means ± S.E.M. #P < 0.05 compa2.8. Cell cycle analysis
After induction of apoptosis, adherent and non-adherent cells were
collected by centrifugation and ﬁxed with cold ethanol (70% vol/vol).
The cells were then washed, resuspended in PBS, and incubated with
RNAse for 30 min at 37 C. After addition of 0.05% propidium iodide,
cells were analyzed by ﬂow cytometry.
2.9. Statistics
Statistically signiﬁcant diﬀerences between mean values were deter-
mined using paired Students t-test. Diﬀerences were considered statis-
tically signiﬁcant at P < 0.05.3. Results and discussion
3.1. Insulin induces a biphasic eﬀect on beta cells
Insulin is capable of inducing Akt and p70 phosphorylation
in beta cells [4,13]. To assess the eﬀect of long-term treatment
with insulin on beta cell survival, we stimulated beta cells with
insulin from 2 h to 24 h in the absence of glucose but in the
presence of serum. Insulin 10 nM induces at short term Akted caspase-3. (A) Beta cells were cultured in DMEM (1 g/l glucose)
edium for diﬀerent periods of time (from 2 to 24 h) with or without
tting with the corresponding antibodies against phospho-p70S6K (Thr
ometric analysis of four independent experiments from the proteins
red with their corresponding non-insulin-stimulated points.
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of glucose (from 2 to 8 h) (Fig. 1). However, insulins eﬀect on
survival signaling is attenuated at 15 h and was totally im-
paired at 24 h (Fig. 1). In parallel, glucose-deprived beta cells
showed enhanced caspase-3 in its active form (cleaved cas-
pase-3). Under the same experimental conditions, insulin
inhibited cleaved caspase-3 expression at short term, but in-
creased its expression at long-term (Fig. 1).
3.2. Insulin induces beta cell apoptosis in both dose- and
cycloheximide-dependent manner
At 24 h, glucose-deprived beta cells displayed increased cas-
pase-3 activity, increased cleaved caspase-3 levels, an increased
number of haplodiploid cells, and the total cell number was de-
creased (Fig. 2A–D). Under these conditions, there was a shift
from inhibitory to stimulatory eﬀects of insulin on caspase-3
activity and also haplodiploid cell number in a dose-dependent
manner. Opposite eﬀects were observed regarding beta cell
number (Fig. 2B). The stimulatory eﬀect at 24 h of high levels
of insulin (from 10 to 100 nM), on cleaved caspase-3 expres-
sion, was not observed in beta cells lacking IR stimulated
either with insulin at any doses used or stimulated with glucose
(5–16–25 mM) (Fig. 2D). In a recent paper, it has been sug-Fig. 2. Insulin stimulates apoptosis in a dose-dependent manner. (A) Beta ce
doses (100 pM–100 nM) for 24 h. The caspase-3 activity was measured as deta
of insulin from 100 pM to 100 nM. After 24 h violet crystal assay was carried a
doses of insulin were analyzed by ﬂow cytometry as described in material and
receptor (/) were grown in DMEM supplemented with FBS 10% and du
without insulin at diﬀerent doses (100 pM–100 nM) in +/+ and / beta ce
25 mM) in / beta cells (right panel) for 24 h. At the end of the experim
caspase-3 expression. Results are means ± S.E.M. #P < 0.05 compared withgested that low nanomolar concentrations of exogenous insu-
lin (0.2–20 nM) were eﬀective in rescuing both human and
mouse islets from serum withdrawal-induced apoptosis [14].
However, higher concentrations of insulin (200 nM) did not
show additional protective eﬀects. The ability of insulin to
modulate apoptosis was assayed in groups of 3–5 islets cul-
tured in serum-free conditions for 5–7 days [14]. This seems
to point to a dual eﬀect of insulin in the capacity of beta cell
rescue. In our experiments, we are depleting the cells of glucose
during a maximum period of 24 h, in contrast to the serum
deprivation during 5–7 days in that paper. Furthermore, under
glucose deprivation, we clearly observe a dual eﬀect of insulin
on beta cell apoptosis, including the loss of insulins antiapo-
ptotic eﬀectiveness and even the potentiation of cell death. In
a recent paper, it has been suggested that in conditions of en-
ergy stress, hyperactivation of mTORC1 complex, which can
be mediated by growth factors, may induce apoptosis [15]. In
haematopoietic cells, including lymphocytes, Glut1/Hexoki-
nase 1 (HK-1)-expressing cells survive to IL-3 withdrawal,
and this indicates that glucose and its metabolic derivatives be-
come limiting in growth factor deprivation, and their lack con-
tribute to apoptosis [16–18]. Accordingly, our results point out
to the indispensable role of glucose to maintain cell survival inlls were kept in DMEM in free glucose with or without diﬀerent insulin
iled in materials and methods. (B) Beta cells treated with diﬀerent doses
s explained in material and methods. (C) Cells stimulated with diﬀerent
methods. (D) Beta cells with insulin receptor (+/+) and without insulin
ring the next day, beta cells were kept in glucose-free medium with or
lls (left panel) or with insulin in +/+ beta cells or with glucose (5–16–
ent, cells were lysed and western-blot was used to determine cleaved-
glucose-deprived cells.
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drives glucose uptake in beta cells, in an insulin-independent
manner. In the absence of glucose, a persistent presence of
growth factors would be deleterious for the beta cells, and
could stimulate apoptosis [19]. In addition, we observed that
cell death induced by insulin in glucose-deprived beta cells
was both caspase-8 and FAS-FADD association independent,
while cytochrome c increased within cytosolic compartment
(data not shown), indicating the involvement of the intrinsic
pathway in the apoptosis of glucose-deprived beta cells.
The presence of cycloheximide (5 lg/ml) abolished caspase-3
activity, cleaved caspase-3 protein and also the number of
haplodiploid cells induced by insulin treatment in glucose-de-
prived beta cells (Fig. 3A, B, and D). Accordingly, cyclohexi-
mide treatment increased the number of viable cells
(Fig. 3C). All of these data suggest a protection role of cyclo-
heximide in glucose-deprived beta cells either in the presence
or in the absence of insulin. This is consistent with the occur-
rence of a protein or a group of proteins with proapoptotic
function that are continuously produced when cells are glu-
cose-deprived. In addition, insulin treatment for 15–24 h en-
hanced the apoptotic eﬀect induced by glucose deprivation.
Under certain conditions, this process can be suppressed by
inhibitors of either RNA or protein synthesis, suggesting that
its induction occurs after speciﬁc protein expression [20]. It hasFig. 3. Beta cell death is cycloheximide-dependent. (A) Cells were kept in DM
before the addition of insulin 10 nM or glucose 5 mM for 24 h in +/+ or /
with antibodies against cleaved-caspase-3 and beta-actin. (B) Caspase-3 activ
were grown as indicated in material and methods. Then, crystal violet assay w
cells were analyzed by ﬂow cytometry as described in material and methods
*P < 0.05 compared with glucose-deprived beta cells.been shown that cycloheximide treatment can both induce or
inhibit cell apoptosis depending on cell type and microenviron-
ment [21,22]. Members of the bcl-2 protooncogene family en-
code proteins that function either to promote or to inhibit
apoptosis [23,24]. Anti-apoptotic products of this gene family,
such as Bcl-2 and BclxL, prevent programmed cell death in re-
sponse to a wide variety of stimuli [23]. In fact, over expression
of BclxL can prevent cell death in beta cells [25]. In contrast,
the proapoptotic protein bax has been implicated in beta cell
death in response to cytokines [26]. In a recent paper it has
been demonstrated that bad and glucokinase reside in a mito-
chondrial complex and this seems to integrate glycolysis and
apoptosis in hepatocytes [27]. Then, we analyzed the role of
diﬀerent proteins of bcl-2 family in the absence of glucose or
in the presence of several concentrations of glucose, stimulated
or not with insulin. We observed an activation of diﬀerent
proapoptotic proteins (cleaved caspase-3, Bax, and BclxS)
and an inhibitory eﬀect on BclxL expression in insulin-stimu-
lated glucose-deprived beta cells (Fig. 4A). In addition, we
observed by light microscopy, an increase of cell death in
glucose-deprived beta cells stimulated with insulin, which
was reversed by increasing glucose concentrations (Fig. 4B).
All of these data suggest a proapoptotic eﬀect of insulin in
the absence of glucose and an antiapoptotic eﬀect of insulin
in the presence of diﬀerent concentrations of glucose.EM in free glucose with or without cycloheximide (5 lg/ml) for 30 min
beta cells, respectively. Total protein was analyzed by immunoblotting
ity was measured as detailed in materials and methods. (C) Beta cells
as carried to determine the relative number of surviving cells. (D) Beta
. Results are means ± S.E.M. #P < 0.05 compared with 10% FBS and
Fig. 4. Role of glucose in the apoptosis induced by insulin. (A) Beta cells were analyzed by immunoblotting with the corresponding antibodies
against BclxL, BclxS, cleaved caspase-3, bax and beta-actin. (B) Representative light microscopy view of beta cells with increasing concentrations of
glucose with or without insulin.
C. Guillen et al. / FEBS Letters 582 (2008) 3855–3860 38593.3. Concluding remarks
Insulin inhibits apoptosis and can induce beta cell prolifera-
tion [5–9]. In insulin-resistant states, there is a chronic compen-
satory hyperinsulinemia produced by pancreatic beta cells.
Ultimately, there is a failure in the compensatory mechanism
as the beta cell mass and function is progressively deteriorated.
There is evidence that apoptosis is one of the mechanisms
underlying the beta cell mass reduction, but the speciﬁc molec-
ular processes are mostly unknown [2,28]. At this stage, we
propose that insulin could be, at least in part, a possible medi-
ator of the pancreatic beta cell apoptosis in the progress to
type 2 diabetes. We observed that insulin is capable to increase
both cleaved caspase-3 protein and activity, increase apoptosis,
and diminish cell number. Furthermore, we observed a process
that is dependent of protein synthesis. All of these data suggest
that, under certain environmental conditions, the prolonged
exposure to high levels of insulin may undergo pancreatic beta
cell damage.References
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